| Aktie | Ticker | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 2.679.121.858 $ | +682.669.598 $ | +111,6 % | 2.024.517.832 $ | +629.729.845 $ | +42,5 % | 1.776.690.536 $ | +442.253.960 $ | +75,6 % | 1.334.436.576 $ | +218.525.497 $ | +134,2 % | ||
| Apogee Therapeutics, Inc. | APGE | 714.882.829 $ | +73.806.960 $ | +11,5 % | 641.075.869 $ | +303.636.226 $ | +90,0 % | 337.439.643 $ | -31.425.288 $ | -8,5 % | 368.864.931 $ | +51.554.458 $ | +16,2 % |
| Erasca, Inc. | ERAS | 265.073.898 $ | +198.645.549 $ | +299,0 % | 66.428.349 $ | +27.499.908 $ | +70,6 % | 38.928.441 $ | +16.249.946 $ | +71,7 % | 22.678.495 $ | +462.279 $ | +2,1 % |
| Oruka Therapeutics, Inc. | ORKA | 203.480.393 $ | +77.741.540 $ | +61,8 % | 125.738.853 $ | +45.964.583 $ | +57,6 % | 79.774.270 $ | +33.270.392 $ | +71,5 % | 46.503.878 $ | +3.941.007 $ | +9,3 % |
| Metsera, Inc. | 196.272.142 $ | +89.565.808 $ | +83,9 % | 106.706.334 $ | +4.613.314 $ | +4,5 % | |||||||
| Spyre Therapeutics, Inc. | SYRE | 185.893.997 $ | +65.158.721 $ | +54,0 % | 120.735.276 $ | +75.727.168 $ | +168,3 % | 45.008.108 $ | +4.806.951 $ | +12,0 % | 40.201.157 $ | -3.128.546 $ | -7,2 % |
| OCULAR THERAPEUTIX, INC | OCUL | 87.638.463 $ | -1.172.278 $ | -1,3 % | 88.810.741 $ | -65.046.750 $ | -42,3 % | 153.857.491 $ | +35.421.844 $ | +29,9 % | 118.435.647 $ | +24.886.801 $ | +26,6 % |
| KalVista Pharmaceuticals, Inc. | KALV | 130.331.383 $ | +21.658.275 $ | +19,9 % | 108.673.108 $ | +26.714.071 $ | +32,6 % | 81.959.037 $ | +5.887.862 $ | +7,7 % | 76.071.175 $ | -1.292.812 $ | -1,7 % |
| Viridian Therapeutics, Inc.\DE | VRDN | 75.945.788 $ | -44.884.116 $ | -37,1 % | 120.829.904 $ | +37.041.044 $ | +44,2 % | 83.788.860 $ | +29.508.588 $ | +54,4 % | 54.280.272 $ | +1.941.355 $ | +3,7 % |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | 99.025.600 $ | +57.815.600 $ | +140,3 % | 41.210.000 $ | +3.402.402 $ | +9,0 % | 37.807.598 $ | +19.177.598 $ | +102,9 % | 18.630.000 $ | -13.012.926 $ | -41,1 % |
| Damora Therapeutics, Inc. | GLTO | 93.333.111 $ | +93.333.111 $ | ||||||||||
| Cidara Therapeutics, Inc. | 90.664.419 $ | +59.534.443 $ | +191,2 % | 31.129.976 $ | +8.480.278 $ | +37,4 % | |||||||
| Savara Inc | SVRA | 75.022.448 $ | -7.832.013 $ | -9,5 % | 82.854.461 $ | +37.583.137 $ | +83,0 % | 45.271.324 $ | +25.015.204 $ | +123,5 % | 20.256.120 $ | +11.232.460 $ | +124,5 % |
| Enliven Therapeutics, Inc. | ELVN | 67.672.175 $ | +17.986.678 $ | +36,2 % | 49.685.497 $ | -16.357.499 $ | -24,8 % | 66.042.996 $ | -14.725.204 $ | -18,2 % | 80.768.200 $ | +1.530.006 $ | +1,9 % |
| Oric Pharmaceuticals, Inc. | ORIC | 54.731.423 $ | +8.299.862 $ | +17,9 % | 46.431.561 $ | -32.731.059 $ | -41,3 % | 79.162.620 $ | +12.204.237 $ | +18,2 % | 66.958.383 $ | +49.199.882 $ | +277,0 % |
| Cogent Biosciences, Inc. | COGT | 76.980.000 $ | +5.940.000 $ | +8,4 % | 71.040.000 $ | +13.600.000 $ | +23,7 % | 57.440.000 $ | +23.296.149 $ | +68,2 % | 34.143.851 $ | +94.229 $ | +0,3 % |
| CytomX Therapeutics, Inc. | CTMX | 46.915.983 $ | -19.376.007 $ | -29,2 % | 66.291.990 $ | +16.650.805 $ | +33,5 % | 49.641.185 $ | +17.929.553 $ | +56,5 % | 31.711.632 $ | +31.711.632 $ | |
| Maze Therapeutics, Inc. | MAZE | 47.820.715 $ | -16.336.499 $ | -25,5 % | 64.157.214 $ | +32.243.374 $ | +101,0 % | 31.913.840 $ | +31.913.840 $ | ||||
| Vor Biopharma Inc. | VOR | 54.264.267 $ | +28.839.808 $ | +113,4 % | 25.424.459 $ | +1.066.115 $ | +4,4 % | 24.358.344 $ | +24.358.344 $ | ||||
| Jade Biosciences, Inc. | JBIO | 45.246.114 $ | -4.444.103 $ | -8,9 % | 49.690.217 $ | +21.898.476 $ | +78,8 % | 27.791.741 $ | -4.379.695 $ | -13,6 % | 32.171.436 $ | +32.171.436 $ | |
| Abivax S.A. | ABVX | 48.964.292 $ | +38.669.075 $ | +375,6 % | 10.295.217 $ | +1.884.092 $ | +22,4 % | ||||||
| enGene Therapeutics Inc. | ENGN | 32.493.329 $ | -10.592.539 $ | -24,6 % | 43.085.868 $ | +8.618.860 $ | +25,0 % | 34.467.008 $ | +16.098.061 $ | +87,6 % | 18.368.947 $ | -4.238.988 $ | -18,8 % |
| Dyne Therapeutics, Inc. | DYN | 39.413.043 $ | -3.108.695 $ | -7,3 % | 42.521.738 $ | +15.021.739 $ | +54,6 % | 27.499.999 $ | +6.804.347 $ | +32,9 % | 20.695.652 $ | -2.043.478 $ | -9,0 % |
| CRESCENT BIOPHARMA, INC. | CBIO | 39.193.791 $ | +13.889.580 $ | +54,9 % | 25.304.211 $ | +8.802.508 $ | +53,3 % | 16.501.703 $ | -5.898.422 $ | -26,3 % | 22.400.125 $ | +21.770.125 $ | +3.455,6 % |
| Zura Bio Ltd | ZURA | 38.288.191 $ | +10.279.788 $ | +36,7 % | 28.008.403 $ | +7.955.238 $ | +39,7 % | 20.053.165 $ | +15.190.388 $ | +312,4 % | 4.862.777 $ | -1.617.107 $ | -25,0 % |
| Pharvaris N.V. | PHVS | 16.831.245 $ | -19.206.867 $ | -53,3 % | 36.038.112 $ | -12.831.592 $ | -26,3 % | ||||||
| RELMADA THERAPEUTICS, INC. | RLMD | 33.709.925 $ | +33.709.925 $ | ||||||||||
| Upstream Bio, Inc. | UPB | 31.746.441 $ | +9.751.946 $ | +44,3 % | 21.994.495 $ | -3.208.108 $ | -12,7 % | 25.202.603 $ | +11.155.251 $ | +79,4 % | |||
| CYBIN INC. | HELP | 18.487.939 $ | -12.925.306 $ | -41,1 % | 31.413.245 $ | +31.413.245 $ | |||||||
| TENAX THERAPEUTICS, INC. | TENX | 26.787.439 $ | +23.456.481 $ | +704,2 % | 3.330.958 $ | +2.763.229 $ | +486,7 % | 567.729 $ | -796.852 $ | -58,4 % | |||
| Adlai Nortye Ltd. | ANL | 22.232.099 $ | +22.232.099 $ | ||||||||||
| Century Therapeutics, Inc. | IPSC | 19.652.174 $ | +18.463.093 $ | +1.552,7 % | |||||||||
| Cullinan Therapeutics, Inc. | CGEM | 19.609.303 $ | +5.326.665 $ | +37,3 % | 14.282.638 $ | +6.099.446 $ | +74,5 % | 8.183.192 $ | -2.207.944 $ | -21,2 % | 10.391.136 $ | -55.199 $ | -0,5 % |
| Surrozen, Inc./DE | SRZN | 18.437.280 $ | +4.133.039 $ | +28,9 % | 14.304.241 $ | +6.148.925 $ | +75,4 % | 8.155.316 $ | +2.496.913 $ | +44,1 % | 5.658.403 $ | -1.721.572 $ | -23,3 % |
| Astria Therapeutics, Inc. | 17.889.493 $ | +4.718.108 $ | +35,8 % | 13.171.385 $ | +49.147 $ | +0,4 % | |||||||
| Septerna, Inc. | SEPN | 12.160.526 $ | -4.868.801 $ | -28,6 % | 17.029.327 $ | +5.540.029 $ | +48,2 % | 11.489.298 $ | +5.776.710 $ | +101,1 % | 5.712.588 $ | +5.712.588 $ | |
| Korro Bio, Inc. | KRRO | 11.427.540 $ | +11.427.540 $ | ||||||||||
| Alto Neuroscience, Inc. | ANRO | 11.240.000 $ | +11.240.000 $ | ||||||||||
| Artiva Biotherapeutics, Inc. | ARTV | 10.365.624 $ | +3.460.573 $ | +50,1 % | 6.905.051 $ | +2.285.588 $ | +49,5 % | 4.619.463 $ | +2.189.014 $ | +90,1 % | 2.430.449 $ | -2.398.258 $ | -49,7 % |
| Perceptive Capital Solutions Corp | PCSC | 7.950.000 $ | -15.000 $ | -0,2 % | 7.965.000 $ | +240.000 $ | +3,1 % | ||||||
| CASI Pharmaceuticals, Inc. | CASIF | 839.170 $ | -799.680 $ | -48,8 % | 1.638.850 $ | +473.884 $ | +40,7 % | 1.164.966 $ | -967.513 $ | -45,4 % | |||
| X4 Pharmaceuticals, Inc | XFOR | 1.365.068 $ | +1.365.068 $ | ||||||||||
| 2.679.121.858 $ | +682.669.598 $ | +111,6 % | 2.024.517.832 $ | +629.729.845 $ | +42,5 % | 1.776.690.536 $ | +442.253.960 $ | +75,6 % | 1.334.436.576 $ | +218.525.497 $ | +134,2 % | ||